In vitro AP model results demonstrated that siRNA-mediated silencing of NCOA4 (si-NCOA4) significantly reduced NCOA4 and LC3 II/I expression, while elevating FTH1 and GPX4 expression (Fig. 7Q-S). The gene discussed is FTH1; the disease is alkaline phosphatase measurement.